These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33123031)

  • 1. ACE2, COVID-19 Infection, Inflammation, and Coagulopathy: Missing Pieces in the Puzzle.
    Abassi Z; Higazi AAR; Kinaneh S; Armaly Z; Skorecki K; Heyman SN
    Front Physiol; 2020; 11():574753. PubMed ID: 33123031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptors: Impact for COVID-19 severity.
    Aksoy H; Karadag AS; Wollina U
    Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy with RAS inhibitors during the COVID-19 pandemic.
    Spaccarotella C; Mazzitelli M; Migliarino S; Curcio A; De Rosa S; Torti C; Indolfi C
    J Cardiovasc Med (Hagerstown); 2021 May; 22(5):329-334. PubMed ID: 33795584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19.
    Issa H; Eid AH; Berry B; Takhviji V; Khosravi A; Mantash S; Nehme R; Hallal R; Karaki H; Dhayni K; Faour WH; Kobeissy F; Nehme A; Zibara K
    Front Med (Lausanne); 2021; 8():620990. PubMed ID: 33816521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
    Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
    G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19, ACE2, and the cardiovascular consequences.
    South AM; Diz DI; Chappell MC
    Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1084-H1090. PubMed ID: 32228252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating angiotensin converting enzyme 2 and COVID-19.
    Leowattana W; Leowattana T; Leowattana P
    World J Clin Cases; 2022 Dec; 10(34):12470-12483. PubMed ID: 36579082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7)-A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic.
    Heyman SN; Walther T; Abassi Z
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33805760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
    Tseng YH; Yang RC; Lu TS
    Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.
    Carpenter RM; Young MK; Petri WAO; Lyons GR; Gilchrist C; Carey RM; Petri WA
    mSphere; 2022 Aug; 7(4):e0022022. PubMed ID: 35913134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells.
    Caputo I; Caroccia B; Frasson I; Poggio E; Zamberlan S; Morpurgo M; Seccia TM; Calì T; Brini M; Richter SN; Rossi GP
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
    Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
    Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
    J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
    Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.
    Saponaro F; Rutigliano G; Sestito S; Bandini L; Storti B; Bizzarri R; Zucchi R
    Front Mol Biosci; 2020; 7():588618. PubMed ID: 33195436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage.
    Kirtipal N; Kumar S; Dubey SK; Dwivedi VD; Gireesh Babu K; Malý P; Bharadwaj S
    Infect Genet Evol; 2022 Apr; 99():105254. PubMed ID: 35217145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System.
    Sansoè G; Aragno M
    J Renin Angiotensin Aldosterone Syst; 2023; 2023():3362391. PubMed ID: 37476705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases.
    Tanzadehpanah H; Lotfian E; Avan A; Saki S; Nobari S; Mahmoodian R; Sheykhhasan M; Froutagh MHS; Ghotbani F; Jamshidi R; Mahaki H
    Biomed Pharmacother; 2023 Oct; 166():115321. PubMed ID: 37597321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.